[UPDATED 11/19/2013] The FDA Class 1 Recall Notice is now available.
[Originally Posted 11/15/2013]
AUDIENCE: Health Professional, Cardiology, Risk Management
ISSUE: Medtronic, Inc.announced that FDA has classified the company's recently initiated voluntary field action related to certain guidewire. Based on an internal investigation following a limited number of complaints, including one patient injury, Medtronic began notifying hospitals and distributors worldwide the week of Oct. 21 that some models of its guidewires from recent lots have the potential for the coating on their surface to delaminate and detach. The notification requested that all potentially affected units be quarantined immediately and returned to the company as soon as possible for credit and replacement.
BACKGROUND: The guidewires covered by this recall are designed to facilitate percutaneous coronary interventions or the placement of left ventricular leads for cardiac rhythm devices. They include specific lots from the following eight product lines that were manufactured after mid-April 2013:
RECOMMENDATION: Additional information about the recall, including the lot numbers of affected product, is accessible through the Medtronic website . Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
[11/15/2013 - Firm Press Release - Medtronic]
[11/19/2013 - Recall Notice - FDA]